Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

SELL
$36.12 - $41.79 $3.62 Million - $4.19 Million
-100,246 Reduced 93.59%
6,866 $251,000
Q1 2023

Apr 06, 2023

SELL
$39.39 - $51.28 $9,296 - $12,102
-236 Reduced 0.22%
107,112 $4.37 Million
Q4 2022

Jan 09, 2023

BUY
$41.75 - $54.5 $160,236 - $209,171
3,838 Added 3.71%
107,348 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $138,762 - $169,394
3,171 Added 3.16%
103,510 $4.53 Million
Q2 2022

Jul 12, 2022

SELL
$46.53 - $55.17 $466,230 - $552,803
-10,020 Reduced 9.08%
100,339 $5.31 Million
Q1 2022

Apr 13, 2022

BUY
$45.75 - $56.69 $584,136 - $723,817
12,768 Added 13.08%
110,359 $5.71 Million
Q4 2021

Jan 13, 2022

BUY
$41.32 - $61.25 $36,733 - $54,451
889 Added 0.92%
97,591 $5.76 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $196,878 - $252,906
5,016 Added 5.47%
96,702 $4.16 Million
Q2 2021

Jul 15, 2021

BUY
$35.91 - $40.68 $141,162 - $159,913
3,931 Added 4.48%
91,686 $3.64 Million
Q1 2021

Apr 21, 2021

BUY
$33.49 - $37.77 $168,454 - $189,983
5,030 Added 6.08%
87,755 $3.39 Million
Q4 2020

Jan 20, 2021

BUY
$33.47 - $42.56 $2.46 Million - $3.13 Million
73,522 Added 798.89%
82,725 $3.05 Million
Q3 2020

Oct 15, 2020

BUY
$31.75 - $37.25 $41,275 - $48,425
1,300 Added 16.45%
9,203 $340,000
Q2 2020

Jul 08, 2020

BUY
$30.12 - $36.54 $238,038 - $288,775
7,903 New
7,903 $273,000
Q1 2020

Apr 06, 2020

SELL
$27.03 - $38.62 $516,218 - $737,564
-19,098 Closed
0 $0
Q4 2019

Jan 10, 2020

BUY
$32.92 - $37.36 $628,706 - $713,501
19,098 New
19,098 $743,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Trinity Legacy Partners, LLC Portfolio

Follow Trinity Legacy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Legacy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Legacy Partners, LLC with notifications on news.